The distribution of hormonal receptor status was also similar between the 2 genes, with 53.3% (8 of 15) of RAD51D breast cancers being ER negative and 46.7% (7 of 15) being triple-negative breast cancers. This evidence concerns the gene NR4A1 and breast carcinoma.